Ritz Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-10-2024
- Paid Up Capital ₹ 0.25 M
as on 23-10-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.18 Cr
as on 23-10-2024
- Revenue -13.28%
(FY 2023)
- Profit 1.40%
(FY 2023)
- Ebitda 6.06%
(FY 2023)
- Net Worth 27.41%
(FY 2023)
- Total Assets 28.19%
(FY 2023)
About Ritz Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.25 M.
The company currently has active open charges totaling ₹2.18 Cr.
Dilipkumar Bhogilal, Samir Shah, and Tanvi Shah serve as directors at the Company.
- CIN/LLPIN
U24230GJ2019PTC106181
- Company No.
106181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2019
- Date of AGM
17 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ritz Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilipkumar Bhogilal  | Director | 21-Jan-2019 | Current |
| Samir Shah | Director | 21-Jan-2019 | Current |
| Tanvi Shah | Director | 12-Nov-2021 | Current |
Financial Performance of Ritz Formulations.
Ritz Formulations Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.28% decrease. The company also saw a slight improvement in profitability, with a 1.4% increase in profit. The company's net worth Soared by an impressive increase of 27.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ritz Formulations?
In 2023, Ritz Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kingston Club & Spa Private LimitedActive 12 years 1 monthDilipkumar Bhogilal and Samir Shah are mutual person
Azillian Healthcare Private LimitedActive 19 years 13 daysDilipkumar Bhogilal, Samir Shah and 1 more are mutual person
- Medico Medserve India Private LimitedActive 7 years 7 months
Dilipkumar Bhogilal and Samir Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Sep 2020 | ₹1.09 Cr | Open |
Others Creation Date: 04 Sep 2020 | ₹1.09 Cr | Open |
How Many Employees Work at Ritz Formulations?
Unlock and access historical data on people associated with Ritz Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ritz Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ritz Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
